The center will launch with about 40 principal investigators, as well as 250 graduate students, postdoctoral fellows, computer scientists and other support staff. Research will focus on integrating genomics into clinical care across Mount Sinai; combining genomic data with patient health records and wearable device data to model, predict and develop treatments for disease progression; and enhancing imaging technologies with AI, computer vision and augmented reality.
The research hub is expected to open in late 2021. Funding for the estimated $100 million project was led by a donation of an undisclosed amount from Blackstone Group’s Hamilton “Tony” James and his wife Amabel, according to Bloomberg.
More articles about AI:
AI-powered low-dose CT imaging is faster, safer, more accurate than other methods
5 hospitals, health systems already implementing AI
IBM Watson Health, Medtronic app predicts hypoglycemic events with up to 90% accuracy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
